Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system

Epstein-Barr virus (EBV) targeted therapeutic strategies for viral associated malignant diseases have received only perfunctory consideration, first, because latent herpesviruses have been intractable to antiviral chemotherapy and, second, because the role EBV has in maintenance of the malignant cel...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Lancet (British edition) 2000-10, Vol.356 (9240), p.1493-1494
Hauptverfasser:	Slobod, Karen S, Taylor, Gregory H, Sandlund, John T, Furth, Priscilla, Helton, Kathleen J, Sixbey, John W
Format:	Artikel
Sprache:	eng
Schlagworte:	Acquired immune deficiency syndrome Adolescent Adult AIDS Antibiotics. Antiinfectious agents. Antiparasitic agents Antiretroviral agents Antiviral agents Biological and medical sciences Brain - drug effects Brain - pathology Brain Neoplasms - drug therapy Brain Neoplasms - virology Central nervous system Chemotherapy Cytotoxicity Deoxyribonucleic acid DNA Drug dosages Drug resistance Drug therapy Edema Epstein-Barr virus Epstein-Barr Virus Infections - drug therapy Epstein-Barr Virus Infections - virology Female Herpesvirus 4, Human - drug effects HIV Human immunodeficiency virus Humans Hydroxyurea Hydroxyurea - therapeutic use Irradiation Lesions Lymphocytes Lymphoma Lymphoma, AIDS-Related - drug therapy Lymphoma, AIDS-Related - virology Magnetic Resonance Imaging Male Medical sciences Nervous system NMR Nuclear magnetic resonance Patients Pharmacology. Drug treatments Toxoplasmosis Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!